Literature DB >> 7475423

Variation in the use of red blood cell transfusions. A study of four common medical and surgical conditions.

P B Hasley1, J R Lave, B H Hanusa, V C Arena, G Ramsey, W N Kapoor, M J Fine.   

Abstract

This study assessed variation in red cell transfusion practice among adult patients hospitalized with ulcer disease (ULCER), and those undergoing coronary artery bypass grafting (CABG), hip surgery (HIP), or total knee replacement (KNEE). The study design was a retrospective analysis of the 1989 MedisGroups Hospital Comparative Database, and the participants were adult patients presenting for their first admission with ULCER (N = 4,664), CABG (N = 6,812), HIP (N = 4,131) or KNEE (N = 3,042) in the MedisGroups Hospital Comparative Database. Outcome measures were whether a patient was transfused, and the number of units transfused. Logistic regression was used to analyze the decision to transfuse, and linear regression to analyze the number of units transfused. In these analyses, patient characteristics, hospital characteristics, and unique hospital identity were used as independent variables. The percentage of patients transfused was ULCER 50%, CABG 81%, HIP 69%, and KNEE 51%. The range among hospitals in the percentage of patients transfused was ULCER 11% to 76%, CABG 51% to 100%, HIP 36% to 95%, and KNEE 9% to 97%. When only patient characteristics were entered in the linear regression analyses, the R2 values were ULCER 0.33, CABG 0.11, HIP 0.11, and KNEE 0.07. When hospital was added, the R2 increased to ULCER 0.38, CABG 0.29, HIP 0.19, and KNEE 0.20 (P < 0.0001 for the change for all analyses). The results of the logistic regression analyses of the probability of transfusion were similar. There is substantial interhospital variation in the proportion of patients transfused and number of units transfused in the four conditions studied. Patient demographic and clinical characteristics explain a substantial proportion of the variation in transfusion practices for ulcer patients, but little of the variation in the three surgical conditions.

Entities:  

Mesh:

Year:  1995        PMID: 7475423

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  8 in total

1.  Patterns of use of hemostatic agents in patients undergoing major surgery.

Authors:  Jason D Wright; Cande V Ananth; Sharyn N Lewin; William M Burke; Zainab Siddiq; Alfred I Neugut; Thomas J Herzog; Dawn L Hershman
Journal:  J Surg Res       Date:  2013-08-13       Impact factor: 2.192

2.  Body mass index, risk of allogeneic red blood cell transfusion, and mortality in elderly patients undergoing hip fracture surgery.

Authors:  A B Pedersen; D Cronin Fenton; M Nørgaard; N R Kristensen; B Kuno Møller; C Erikstrup
Journal:  Osteoporos Int       Date:  2016-04-21       Impact factor: 4.507

3.  Determinants of allogeneic transfusion among patients who had an autologous blood procedure, France.

Authors:  Simone Mathoulin-Pélissier; Louis Rachid Salmi; Charlotte Huët
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  The impact of blood use on patients undergoing coronary artery bypass surgery: a prospective study.

Authors:  A Lako; S Bilali; S Memishaj; A Daka; T Dedej; T Nurka; V Bilali; V Gjylameti
Journal:  G Chir       Date:  2014 Jan-Feb

Review 5.  Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.

Authors:  P A Carless; D A Henry; D M Anthony
Journal:  Cochrane Database Syst Rev       Date:  2003

6.  Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

7.  Predictors of packed red cell transfusion after isolated primary coronary artery bypass grafting--the experience of a single cardiac center: a prospective observational study.

Authors:  Elsayed M Elmistekawy; Lee Errett; Hosam F Fawzy
Journal:  J Cardiothorac Surg       Date:  2009-05-07       Impact factor: 1.637

8.  Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study.

Authors:  Alma B Pedersen; Frank Mehnert; Soren Overgaard; Soren P Johnsen
Journal:  BMC Musculoskelet Disord       Date:  2009-12-29       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.